Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome
A legfontosabb adatok
- Ki végzi
- Timothy J Nelson, MD, PhD
- Hol
- Aurora, Birmingham, Cincinnati, Los Angeles, Minneapolis, New Orleans, Oklahoma City és Philadelphia (Egyesült Államok)Mind a 8 helyszín megnézése
- Azonosító
- Állapot
- Fut, nem toboroz
- Fázis
- 2. fázis
- Résztvevők
- 95 fő vett részt
- Kezdés
- 2019. jún. 6.
- Befejezés
- 2026. febr.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Autologous (self) mononuclear cells derived from umbilical cord blood
- Stage II Surgical repair
- A regiszteradat frissítve
- 2025. július 8.
Ki vehet részt
- Életkor
- Legfeljebb 12 hónap
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 9 feltétel megnézéseKevesebb
Ki vehet részt
- Diagnosis of HLHS or HLHS variant with single right ventricular dependent CHD having undergone Stage I surgical repair and undergoing Stage II surgical repair
- Less than 13 months of age at time of Stage II surgical repair
- Previous participation in the UCB collection protocol with autologous UCB-MNC product that is acceptable for use (treatment arm only)
Ki nem vehet részt
- Any of the following complications of his/her congenital heart disease:; Any condition requiring urgent, or unplanned interventional procedure within 15 days prior to Stage II surgical repair, unless complete and full cardiac recovery is documented by site investigator; Severe pulmonary hypertension (reported in the medical record as >70% systemic pressure); Other clinical concerns as documented by a site investigator that would predict (more likely to happen than not to happen) a risk of severe complications or very poor outcome, not directly related to the stem cell product or its injection procedure, during or after Stage II surgical repair
- History of DMSO reaction (treatment arm only)
- Severe chronic diseases at the discretion of the treating physician
- Extensive extra-cardiac syndromic features
- Known history of cancer
- Parent(s) and/or legal guardian(s) unwilling to have their child participate or unwilling to follow the study procedures
Helyszínek itt: Egyesült Államok
- Children's Hospital ColoradoAurora, Egyesült Államok
- Children's of AlabamaBirmingham, Egyesült Államok
- Cincinnati Children's Hospital and Medical CenterCincinnati, Egyesült Államok
- Children's Hospital of Los AngelesLos Angeles, Egyesült Államok
- Children's Hospitals of MinnesotaMinneapolis, Egyesült Államok
- Ocshner Medical CenterNew Orleans, Egyesült Államok
- Oklahoma University Medical CenterOklahoma City, Egyesült Államok
- Children's Hospital of PhiladelphiaPhiladelphia, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
Researchers want to better understand what happens to the heart when the stem cells are injected directly into the muscle of the right side of the heart during the Stage II palliative surgery for single ventricle patients with hypoplastic left heart syndrome (HLHS) or HLHS variant. Researchers want to see if there are changes in the heart's structure/function following this stem cell-based therapy and compared to children that have not had cell-based therapy.
A vizsgálat 2 csoportja
- TreatmentA vizsgált kezelés
Autologous (self) mononuclear cells derived from umbilical cord blood and that meet all release criteria are injected into the surface of the right heart muscle to achieve the target dose of 1-3 million cells per kilogram body weight . This is a one time treatment at the time of Stage II Glenn surgery .
Kezelés: Autologous (self) mononuclear cells derived from umbilical cord blood és Stage II Surgical repair
- ControlMár használt kezelés, összehasonlításként
Clinical data will be collected before, during and after the Stage II surgical standard of care procedure. Requires additional imaging studies at 3 months that are not standard of care in addition to some blood tests that would be beyond standard of care. Information will be collected to document the clinical outcomes and will be compared with the information from the group receiving the investigational treatment used in this study.
Kezelés: Stage II Surgical repair
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Phase IIb Study of Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Stage II Surgical Repair of Right Ventricular Dependent Variants of Hypoplastic Left Heart Syndrome (AutoCell-S2)
- Publikációk
- A regiszteradat frissítve
- 2025. július 8.